One of the serious problems the world is facing today is the antimicrobial resistance on available antibiotics by most bacterial pathogens and the rising cost of finding effective antimicrobial agents. In recent years...One of the serious problems the world is facing today is the antimicrobial resistance on available antibiotics by most bacterial pathogens and the rising cost of finding effective antimicrobial agents. In recent years, efforts to find new drugs especially from natural sources have been boosted by the demand for an effective cure for infectious diseases. Only the antibacterial activity of <em>apis mellifera</em> honey and not stingless bee honey from western Kenya has been reported. This study was therefore carried out to determine the effect of <em>Plebenia hylderbrandii </em>and <em>Meliponula bocandei </em>honey samples on the growth of control;sensitive cases of Escherichia coli (ATCC 25922) and <em>Staphylococcus aureus</em> (ATCC 25923). Different honey concentrations (1.18% - 17.65% v/v) of the two samples were tested against the two micro-organisms. The samples were screened for their antibacterial potential against <em>Escherichia coli </em>and <em>Staphylococcus aureus</em> by agar well dilution method. The Partial inhibitory concentration (PIC), minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) values were determined by in vitro method. The inhibitory effect of <em>Plebenia hylderbrandii</em> honey on <em>E. coli</em> and <em>S. aureus</em> growth was apparent at concentrations 3.53% and 1.76% (v/v) respectively. On the other hand, the inhibitory effect of <em>Meliponula bocandei </em>honey on <em>S. aureus</em> growth was at concentration 16.47% (v/v). <em>Plebenia hylderbrandii</em> honey had bactericidal effect on both <em>E. coli </em>and <em>S. aureus</em> at concentrations 4.71% and 2.35% (v/v) respectively. However, <em>Meliponula bocandei</em> honey exerted bactericidal effect on <em>S. aureus </em>only at 16.47% (v/v) concentration. <em>Plebenia hylderbrandii </em>honey had higher antibacterial potency and can be a potential source of antibacterial substances. Moreover, the honeys tested in this study showed great antibacterial potential for <em>S. aureus</em>.展开更多
AIM: To understand the pathogen characteristics and its sensitivity against antimicrobial agents in fatal bacterial granuloma after eyelid trauma (FBGT) in vitro, and to provide laboratory evidence for diagnosis. METH...AIM: To understand the pathogen characteristics and its sensitivity against antimicrobial agents in fatal bacterial granuloma after eyelid trauma (FBGT) in vitro, and to provide laboratory evidence for diagnosis. METHODS: The FBGT pathogens were isolaated and cultured with reformed rabbit-brain anaerobic enriched broth (RRAB), and identified by ATB/API 20A system. The minimum inhibiting concentration (MIC) was determined by anaerobic broth dilution method. RESULTS: A total of 22 strains of pathogen were separated from 21 patients with FBGT and identified as Propionibacterium acnes (PA) by ATB/API 20A system. The MIC of ciprofloxacin for 22 PA strains was 0.0625-0.5mg/L, the MIC of penicillin, ampicillin, ampicillin/sulbactam, cefoperazone, lincomycin, and imipenem/cilastatin were 0.125-0.5mg/L, the MIC of ticarcillin/clavulanic acid was 0.250-1.000mg/L, and the MIC of metronidazole was 64-256mg/L. The pathogen of FBGT was strictly anaerobic PA, which growed slowly and better in nutritious RRAB broth. All PA were resistant to metronidazole, but susceptive to other routine antimicrobial agents, such as penicillin, ampicillin and lincomycin. CONCLUSION: FBGT should not be treated with metronidazole. Clinicians should choose combined use of drugs or operation to treat FBGT according to patients' individual condition and the results of drug sensitivity test.展开更多
文摘One of the serious problems the world is facing today is the antimicrobial resistance on available antibiotics by most bacterial pathogens and the rising cost of finding effective antimicrobial agents. In recent years, efforts to find new drugs especially from natural sources have been boosted by the demand for an effective cure for infectious diseases. Only the antibacterial activity of <em>apis mellifera</em> honey and not stingless bee honey from western Kenya has been reported. This study was therefore carried out to determine the effect of <em>Plebenia hylderbrandii </em>and <em>Meliponula bocandei </em>honey samples on the growth of control;sensitive cases of Escherichia coli (ATCC 25922) and <em>Staphylococcus aureus</em> (ATCC 25923). Different honey concentrations (1.18% - 17.65% v/v) of the two samples were tested against the two micro-organisms. The samples were screened for their antibacterial potential against <em>Escherichia coli </em>and <em>Staphylococcus aureus</em> by agar well dilution method. The Partial inhibitory concentration (PIC), minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) values were determined by in vitro method. The inhibitory effect of <em>Plebenia hylderbrandii</em> honey on <em>E. coli</em> and <em>S. aureus</em> growth was apparent at concentrations 3.53% and 1.76% (v/v) respectively. On the other hand, the inhibitory effect of <em>Meliponula bocandei </em>honey on <em>S. aureus</em> growth was at concentration 16.47% (v/v). <em>Plebenia hylderbrandii</em> honey had bactericidal effect on both <em>E. coli </em>and <em>S. aureus</em> at concentrations 4.71% and 2.35% (v/v) respectively. However, <em>Meliponula bocandei</em> honey exerted bactericidal effect on <em>S. aureus </em>only at 16.47% (v/v) concentration. <em>Plebenia hylderbrandii </em>honey had higher antibacterial potency and can be a potential source of antibacterial substances. Moreover, the honeys tested in this study showed great antibacterial potential for <em>S. aureus</em>.
文摘AIM: To understand the pathogen characteristics and its sensitivity against antimicrobial agents in fatal bacterial granuloma after eyelid trauma (FBGT) in vitro, and to provide laboratory evidence for diagnosis. METHODS: The FBGT pathogens were isolaated and cultured with reformed rabbit-brain anaerobic enriched broth (RRAB), and identified by ATB/API 20A system. The minimum inhibiting concentration (MIC) was determined by anaerobic broth dilution method. RESULTS: A total of 22 strains of pathogen were separated from 21 patients with FBGT and identified as Propionibacterium acnes (PA) by ATB/API 20A system. The MIC of ciprofloxacin for 22 PA strains was 0.0625-0.5mg/L, the MIC of penicillin, ampicillin, ampicillin/sulbactam, cefoperazone, lincomycin, and imipenem/cilastatin were 0.125-0.5mg/L, the MIC of ticarcillin/clavulanic acid was 0.250-1.000mg/L, and the MIC of metronidazole was 64-256mg/L. The pathogen of FBGT was strictly anaerobic PA, which growed slowly and better in nutritious RRAB broth. All PA were resistant to metronidazole, but susceptive to other routine antimicrobial agents, such as penicillin, ampicillin and lincomycin. CONCLUSION: FBGT should not be treated with metronidazole. Clinicians should choose combined use of drugs or operation to treat FBGT according to patients' individual condition and the results of drug sensitivity test.
